News
1h
Zacks Investment Research on MSNPharma Stock Roundup: NVO & JAZZ's Q1 Results, AZN's Pipeline UpdateNovo Nordisk NVO and Jazz Pharmaceuticals JAZZ reported their first-quarter results. AstraZeneca’s AZN late-stage asthma ...
The table below is a review of notable updates that occurred in April 2025 for investigational products in development.
With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...
Medicare recipients suffering from obesity must pay out of pocket for weight loss drugs like Wecovy and Zepbound.
With more and more people signing up for weight loss drugs, the potential side effects are starting to attract attention. Helen Coffey speaks to the dentists warning that jabs could have a worrying im ...
Avery is known for songs such as 'Go Screw Yourself (GSY) and 'Meant to Live', but the artist took to social media earlier ...
Andrew Dudum cofounded online pharmacy Hims & Hers eight years ago, when he was 27 years old. He’s now the latest to make a ...
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
We expected miracles; what we got was a legal minefield. As GLP-1 drugs like Ozempic reshape bodies and bottom lines, a ...
Attorney James Gourley details the many legal issues surrounding the GLP-1 drug market and offers advice to companies on how ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Novo Nordisk is collaborating with multiple telehealth organizations in an effort to increase patient access to authentic Wegovy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results